Clinical trial
Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit…
NCT00221962 · University Hospitals Cleveland Medical Center, Other · Completed
Key facts
| NCT number | NCT00221962 |
|---|---|
| Title | Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder) |
| Official title | The Cognitive Effects of Aripiprazole in Children |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 23 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: